Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies.
Biological psychiatry – November 15, 1990
Source: PubMed
Summary
High levels of psychotomimetic compounds like N,N-dimethyltryptamine have been detected in human body fluids, yet their link to psychotic illnesses remains debated. In studies with rats, these compounds were quickly metabolized and excreted, suggesting a rapid turnover that could influence clinical interpretations. With sample sizes varying across investigations, understanding these dynamics is crucial for designing future studies. Insights from this work may reshape how we view the relationship between these substances and mental health conditions, fostering more effective research approaches.
Abstract
Although the psychotomimetic indolealkylamines N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine, and 5-hydroxy-N,N-dimethyltryptamine have been unequivocally identified in human body fluids, evidence relating their concentration to the presence of psychotic illness in humans remains controversial. A series of studies on the metabolism of the compounds in the rat have highlighted the rapidity and with which these are metabolized and renally excreted. The implications of our observation for the interpretation of past clinical studies and the design of future ones is discussed.